Bellerophon Therapeutics, Inc. (11) | Business Finance (6)

Browse by Subcategory

Recent Contracts

Underwriting Agreement by and between Bellerophon Therapeutics, Inc. and Jefferies LLC, dated May 18, 2020 (Filed With SEC on May 20, 2020)
Subscription Agreement by and between Bellerophon Therapeutics, Inc. and Puissance Life Science Opportunities Fund VI, dated May 18, 2020 (Filed With SEC on May 20, 2020)
Form of Securities Purchase Agreement, dated as of March 30, 2020, by and among Bellerophon Therapeutics, Inc. and the Investors (Filed With SEC on March 30, 2020)
Binding Term Sheet and Agreement for Line of Credit Facility dated December 16, 2019 between the Company and the signatories identified therein (Filed With SEC on December 17, 2019)
Form of Warrant Amendment, dated June 28, 2019 (Filed With SEC on July 1, 2019)
Underwriting Agreement, dated January 23, 2019, by and between Bellerophon Therapeutics, Inc. and H.C. Wainwright & Co (Filed With SEC on January 23, 2019)